SureTrader
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

The old timers on IV sometimes have rose

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sts66 Member Profile
 
Followed By 34
Posts 6,201
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/11/2016 11:16:47 AM
Navidea Biopharmaceuticals Enrolls First Patient in Cervical Cancer Study of Lymphoseek® "Business Wire" - 2/11/2016 7:00:00 AM
Navidea Biopharmaceuticals to Present at 2016 BIO CEO & Investor Conference "Business Wire" - 2/4/2016 9:21:00 AM
Navidea Provides Update on Lymphoseek® and Immunodiagnostics Development Pipeline "Business Wire" - 2/2/2016 5:07:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/11/2016 12:33:25 PM
Navidea Meets Guidance With 2015 Unaudited Lymphoseek® Sales of $10.2 Million "Business Wire" - 1/11/2016 6:45:00 AM
Navidea Appoints Anton Gueth Chairman of the Board "Business Wire" - 1/11/2016 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/8/2016 5:32:47 PM
Navidea Biopharmaceuticals Enrolls First Patient in Pediatric Trial of Lymphoseek® "Business Wire" - 1/6/2016 7:30:00 AM
Navidea Biopharmaceuticals to Present at Biotech Showcase 2016 "Business Wire" - 1/4/2016 7:30:00 AM
Lymphoseek® Technically Successful in Evaluation of Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy "Business Wire" - 12/10/2015 4:30:00 PM
Lymphoseek® Reduces Sentinel Lymph Node Biopsy Imaging Time, Facilitating Patient Throughput and Workflow Efficiencies "Business Wire" - 12/3/2015 8:29:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/3/2015 4:21:58 PM
Navidea Biopharmaceuticals to Present at Stifel 2015 Healthcare Conference "Business Wire" - 11/10/2015 7:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2015 5:58:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/6/2015 5:07:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/4/2015 4:50:57 PM
Navidea Reports 2015 Third Quarter Financial Results "Business Wire" - 11/4/2015 7:30:00 AM
Navidea Biopharmaceuticals to Announce Third Quarter 2015 Financial Results on November 4, 2015 "Business Wire" - 10/26/2015 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/20/2015 12:13:31 PM
Navidea Biopharmaceuticals to Present at BIO Investor Forum "Business Wire" - 10/14/2015 7:30:00 AM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 10/9/2015 4:14:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/5/2015 6:03:21 PM
Navidea Biopharmaceuticals Announces Addition to Major Indexes on Tel Aviv Stock Exchange "Business Wire" - 9/28/2015 7:30:00 AM
Macrophage Therapeutics Produces First Two Immunoconstructs "Business Wire" - 9/25/2015 7:30:00 AM
sts66   Wednesday, 04/24/13 08:06:49 PM
Re: hondadriver1973 post# 3569
Post # of 8288 
The old timers on IV sometimes have rose colored glasses on....they refuse to see manipulation.....being shorted by firms supposedly investing in NAVB....even the words "basher" or similar are not allowed by DDB....this just doesn't smell right to me.....and JPM apparently bought some for a 2nd unnamed investor again, same thing as last time....who are these mystery buyers and why are their names being kept a secret?

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist